Welcome to the Jorgensen Lab
For many years, the Jorgensen Research Group has been at the forefront of computational chemistry and molecular design. Below is an outline of our progress:
| 1976-82 | QM studies of organic ions & ion-molecule complexes |
|---|---|
| 1978- | MC for liquids, OPLS force field development |
| 1980- | Solvent effects on conformational equilibria |
| 1980-95 | Development of CAMEO for prediction of products of organic reactions |
| 1983 | TIP3P & TIP4P water models |
| 1984 | Free-energy profiles for SN2 reactions in solution |
| 1985 | 1st FEP calculation: CH3CH3 --> CH3OH in water |
| 1985- | FEP for reactions in solution (QM + MM), ΔGhyd, ion-pairing, pKas, log P, hydrophobic effects, etc. |
| 1988-96 | Molecular recognition/organic host-guest complexes |
| 1989 | Secondary electrostatic effects for G-C, A-T, etc. |
| 1987- | MD and MC for proteins, denaturation, folding, enzymatic rxns |
| 1996- | FEP/MC for protein-ligand binding |
| 1997- | Full QM/MM for organic & enzymatic reactions |
| 2000- | Structure-based drug design, ADME predictions |
| 2001- | Semiempirical molecular orbital method development |
| 2003- | FEP-guided design and synthesis of enzyme inhibitors |
| 2009- | Discovery of MIF antagonists and agonists |
| 2011- | Report of the most potent, non-toxic anti-HIV agents ever discovered |
Newest Publications
370.
Characterization of Biaryl Torsional Energetics and its Treatment in OPLS All-Atom Force Fields.
Dahlgren, M. K.; Schyman, P.; Tirado-Rives, J.; Jorgensen, W. L.
J. Chem. Inf. Model.
2013,
Article ASAP.
doi:10.1021/ci4001597.
369.
Automated Ligand- and Structure-Based Protocol for in Silico Prediction of Human Serum Albumin Binding.
Hall, M. L.; Jorgensen, W. L.; Whitehead, L.
J. Chem. Inf. Model.
2013,
53,
907-922.
doi:10.1021/ci3006098.
368.
Exploring Adsorption of Water and Ions on Carbon Surfaces Using a Polarizable Force Field.
Schyman, P.; Jorgensen, W. L.
J. Phys. Chem. Lett.
2013,
4,
468-474.
doi:10.1021/jz302085c.
367.
Optimization of benzyloxazoles as non-nucleoside inhibitors of HIV-1 reverse transcriptase to enhance Y181C potency.
Bollini, M.; Gallardo-Macias, R.; Spasov, K. A.; Tirado-Rives, J.; Anderson, K. S.; Jorgensen, W. L.
Bioorganic and Medicinal Chemistry Letters
2013,
23,
1110-1113.
doi:10.1016/j.bmcl.2012.11.115.
366.
Crystal Structures of HIV-1 Reverse Transcriptase with Picomolar Inhibitors Reveal Key Interactions for Drug Design.
Frey, K. M.; Bollini, M.; Mislak, A. C.; Cisneros, J. A.; Gallardo-Macias, R.; Jorgensen, W. L.; Anderson, K. S.
J. Am. Chem. Soc.
2012,
134,
19501-19503.
doi:10.1021/ja3092642.
365.
Challenges for Academic Drug Discovery.
Jorgensen, W. L.
Angew. Chem. Int. Ed.
2012,
51,
2-7.
doi:10.1002/anie.201204625.
364.
Virtual Screening & Optimization Yield Low-Nanomolar Inhibitors of the Tautomerase Activity of Plasmodium falciparum Macrophage Migration Inhibitory Factor.
Dahlgren, M.; Baeza Garcia, A.; Hare, A. A.; Tirado-Rives, J.; Leng, L.; Bucala, R.; Jorgensen, W. L.
J. Med. Chem.
2012,
55,
10148-10159.
doi:10.1021/jm301269s.
363.
Small-Molecule Inhibitors of the Interaction between the E3 Ligase VHL and HIF1α.
Buckley, D. L.; Gustafson, J. L.; Van Molle, I.; Roth, A. G.; Seop Tae, H.; Gareiss, P. C.; Jorgensen, W. L.; Ciulli, A.; Crews, C. M.
Angew. Chem. Int. Ed.
2012,
51,
11463-11467.
doi:10.1002/anie.201206231.
362.
Role of Macrophage Migration Inhibitory Factor in the Regulatory T Cell Response of Tumor-Bearing Mice.
Choi, S.; Kim, H. R.; Leng, L.; Kang, I.; Jorgensen, W. L.; Cho, C. S.; Bucala, R.; Kim, W. U.
J. Immunol.
2012,
189,
3905-3913.
doi:10.4049/jimmunol.1102152.
For more details about the specifics of the research, please see the publications page and the research page.
At the 243rd National American Chemical Society meeting, in San Diego, CA, March 2012, Professor Jorgensen recieved the Joel Henry Hildebrand Award in Theoretical and Experimental Chemistry of Liquids. This award is sponsored by the Exxon Mobil Research and Engineering Company and was presented by Dr. Thomas F. Degnan, Jr. Manager, Breakthrough and Leads Generation, Exxon Mobil Research and Engineering Company. Congratulations Dr. Jorgensen!

